Middletown, DE -- (SBWIRE) -- 10/03/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: OncoSec Medical Inc(OTCMKTS:ONCS), North American Oil & Gas Corp(OTCBB:NAMG), Cellceutix Corp(OTCMKTS:CTIX), Bio-Path Holdings Inc(OTCMKTS:BPTH).
OncoSec Medical Inc(OTCMKTS:ONCS) ended higher +4.81% and complete the day at $0.273. The total number of shares changed hands during the day was 2.18 million. After opening at $0.26, the stock hit as high as $0.27. However, it traded between $0.18 and $0.49 over the last twelve months.
OncoSec Medical Incorporated, a drug-medical device and therapeutic company, designs, develops, and commercializes medical approaches for the treatment of solid tumors in the United States
For How Long ONCS will Fight for Profitability? Read This Trend Analysis report
North American Oil & Gas Corp(OTCBB:NAMG) closed yesterday at $0.995, a +0.51% increase. Around 392,414 shares were traded, low from an-average trading volume of 470,370 shares. The company is now valued at around $60.02 million.
North American Oil & Gas Corp. (NAMOG) is a development-stage company. The Company is engaged in oil and gas exploration in California, through its subsidiary Lani.
For How Long NAMG Gloss will Attract Investors? Find out via this report
Cellceutix Corp(OTCMKTS:CTIX) moved +3.39 percent higher at $1.83 and traded between $1.78 and $1.85 after opening the day at $1.84.
Cellceutix Corporation is an early-stage developmental biopharmaceutical company. The Company has acquired exclusive rights to eight different pharmaceutical compound candidates that are designed for treatment of diseases which exist, or may exist in the future.
For How Long CTIX Gloss will Attract Investors? Find out via this report
Bio-Path Holdings Inc(OTCMKTS:BPTH) shares rose, gaining +10.26 percent to close at $2.15. The stock is up around 514.29% this year and 462.53% for the last 12 months. Around 342,796 shares changed hands yesterday, higher from an-average trading volume of 81,028 shares.
Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate
Why Should Investors Buy BPTH After The Recent Gain? Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)